# Star-Close Versus Angio-Seal for Femoral Artery Hemostasis

> **NCT00590356** · PHASE4 · WITHDRAWN · sponsor: **Seung-Jung Park**

## Conditions studied

- Percutaneous Intervention Via Femoral Artery

## Interventions

- **DEVICE:** StarClose®
- **DEVICE:** AngioSeal®

## Key facts

- **NCT ID:** NCT00590356
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590356, "Star-Close Versus Angio-Seal for Femoral Artery Hemostasis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00590356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*